sarepta market cap is just under 10B usd. They have about 2b cash and make about 1b a year before subtracting costs. So they're trading at x10 sales atm, but really are just supported by cash. If you were holding sarepta shares, their cash position would give you confidence, because if the likes of little ANP want to steal the US dmd market, a one billion usd cash payment should fix that problem.
